Aegerion Pharmaceuticals, an emerging biopharmaceutical company, has appointed Mark Fitzpatrick as chief financial officer (CFO). He brings over 15 years of financial management experience in both public and private companies.
Most recently Fitzpatrick was vice president, CFO and assistant secretary at Proteon Therapeutics. Prior to this, he was vice president and CFO, treasurer and assistant secretary with RenaMed Biologics. He also held CFO positions with Dynogen Pharmaceuticals, WorldStreet Corporation and Diacrin. He previously was a senior auditor with Arthur Andersen & Co.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more